Paper33748017
Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
Liang L and 9 others. J Hepatocell Carcinoma, 2021. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml). Papers, record 33748017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33748017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28032546 | Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy. | J Surg Res | 2017 | https://conductscience.org/library/papers/28032546 | PubMed |
| 2 | 30970190 | Hepatocellular Carcinoma. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30970190 | PubMed |
| 3 | 30017783 | Alpha-fetoprotein response following transarterial chemoembolization indicates improved survival for intermediate-stage hepatocellular carcinoma. | HPB (Oxford) | 2019 | https://conductscience.org/library/papers/30017783 | PubMed |
| 4 | 23816006 | Evaluation of alpha-fetoprotein staging system for hepatocellular carcinoma in noncirrhotic patients. | Am Surg | 2013 | https://conductscience.org/library/papers/23816006 | PubMed |
| 5 | 31285588 | Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. | Br J Cancer | 2019 | https://conductscience.org/library/papers/31285588 | PubMed |
| 6 | 23754648 | Partial hepatectomy for ruptured hepatocellular carcinoma. | Br J Surg | 2013 | https://conductscience.org/library/papers/23754648 | PubMed |
| 7 | 29571804 | Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. | Eur J Radiol | 2018 | https://conductscience.org/library/papers/29571804 | PubMed |
| 8 | 31954491 | Advances in resection and transplantation for hepatocellular carcinoma. | J Hepatol | 2020 | https://conductscience.org/library/papers/31954491 | PubMed |
| 9 | 26813914 | A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma. | Ann Surg | 2016 | https://conductscience.org/library/papers/26813914 | PubMed |
| 10 | 30665869 | Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/30665869 | PubMed |
| 11 | 29376136 | Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. | Hepatoma Res | 2018 | https://conductscience.org/library/papers/29376136 | PubMed |
| 12 | 30548884 | Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. | Hepatology | 2019 | https://conductscience.org/library/papers/30548884 | PubMed |
| 13 | 32472951 | Early and Late Recurrence of Hepatitis B Virus-Associated Hepatocellular Carcinoma. | Oncologist | 2020 | https://conductscience.org/library/papers/32472951 | PubMed |
| 14 | 29805966 | Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity. | Can J Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29805966 | PubMed |
| 15 | 24123097 | On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir. | Hepatology | 2014 | https://conductscience.org/library/papers/24123097 | PubMed |
| 16 | 12547409 | Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. | J Hepatol | 2003 | https://conductscience.org/library/papers/12547409 | PubMed |
| 17 | 22535689 | Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. | Hepatology | 2012 | https://conductscience.org/library/papers/22535689 | PubMed |
| 18 | 23548745 | Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers. | Dig Surg | 2012 | https://conductscience.org/library/papers/23548745 | PubMed |
| 19 | 31829979 | Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/31829979 | PubMed |
| 20 | 29624699 | Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. | Hepatology | 2018 | https://conductscience.org/library/papers/29624699 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42068148 | Association Between Multi-Laboratory Parameters Pre- and Post-Treatment and Pathological Features and Their Values in Clinical Decision in Primary Hepatic Carcinoma. | J Clin Lab Anal | 2026 | https://conductscience.org/library/papers/42068148 | PubMed |
| 41971433 | Multiphasic CT-based multimodal deep learning model for predicting early hepatocellular carcinoma recurrence following liver transplantation. | Front Oncol | 2026 | https://conductscience.org/library/papers/41971433 | PubMed |
| 40636774 | Hyper-Relapse Disease is a Special Pattern of Relapse of Hepatocellular Carcinoma After Curative Hepatectomy: A Retrospective Cohort Study. | J Hepatocell Carcinoma | 2025 | https://conductscience.org/library/papers/40636774 | PubMed |
| 39917418 | Prognostic Value of the ASAP Score for Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multicenter Analysis of 1,239 Patients. | J Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/39917418 | PubMed |
| 39555448 | The impact of tumor burden score on prognosis in patients after radical resection of hepatocellular carcinoma: a single-center retrospective study. | Front Oncol | 2024 | https://conductscience.org/library/papers/39555448 | PubMed |
| 38907676 | Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. | Oncologist | 2024 | https://conductscience.org/library/papers/38907676 | PubMed |
| 38903723 | Prognostic implications of preoperative, postoperative, and dynamic changes of alpha-fetoprotein and des-gamma (γ)-carboxy prothrombin expression pattern for hepatocellular carcinoma after hepatic resection: a multicenter observational study. | Front Oncol | 2024 | https://conductscience.org/library/papers/38903723 | PubMed |
| 37925654 | Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/37925654 | PubMed |
| 37746650 | Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | https://conductscience.org/library/papers/37746650 | PubMed |
| 36755690 | Whole-Transcriptome Sequencing Combined with High-Dimensional Proteomic Technologies Reveals the Potential Value of miR-135b-5p as a Biomarker for Hepatocellular Carcinoma. | Biomed Res Int | 2023 | https://conductscience.org/library/papers/36755690 | PubMed |
| 36686731 | Association between early response of alpha-fetoprotein and treatment efficacy of systemic therapy for advanced hepatocellular carcinoma: A multicenter cohort study from China. | Front Oncol | 2022 | https://conductscience.org/library/papers/36686731 | PubMed |
| 36207940 | [The consensus on tertiary prevention of primary liver cancer (2022 version)]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36207940 | PubMed |
| 35986784 | Short- and long-term outcomes of laparoscopic versus open liver resection for large hepatocellular carcinoma: a propensity score study. | Surg Today | 2023 | https://conductscience.org/library/papers/35986784 | PubMed |
| 35273701 | Orthotopic liver transplantation improves postoperative quality of life, survival rate and reduces recurrence rate in patients with liver cancer. | Am J Transl Res | 2022 | https://conductscience.org/library/papers/35273701 | PubMed |
| 35178834 | E2F1-mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10. | Cancer Sci | 2022 | https://conductscience.org/library/papers/35178834 | PubMed |
| 35127471 | Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection. | Front Oncol | 2021 | https://conductscience.org/library/papers/35127471 | PubMed |
| 34408472 | The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/34408472 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33748017
GET https://conductscience.org/api/papers/v1/33748017/references?page=2